Submission Details
| 510(k) Number | K030754 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 10, 2003 |
| Decision Date | July 11, 2003 |
| Days to Decision | 123 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
K030754 is an FDA 510(k) clearance for the A/C ENZYMATIC HOMOCYSTEINE ASSAY, a Urinary Homocystine (nonquantitative) Test System (Class II — Special Controls, product code LPS), submitted by Anticancer, Inc. (San Diego, US). The FDA issued a Cleared decision on July 11, 2003, 123 days after receiving the submission on March 10, 2003. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.1377.
| 510(k) Number | K030754 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 10, 2003 |
| Decision Date | July 11, 2003 |
| Days to Decision | 123 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
| Product Code | LPS — Urinary Homocystine (nonquantitative) Test System |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1377 |